Report Detail
Global PEGylated Proteins Market Growth 2019-2024
- RnM2872455 |
- 04 February, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturers and suppliers lose their bargaining power. Consumers are able to purchase competitor's products if they are not satisfied with product price or quality. In order for suppliers to tackle the challenge of threat of substitutes, they have to innovate products which meet the needs of their target market segments.
According to this study, over the next five years the PEGylated Proteins market will register a 3.9% CAGR in terms of revenue, the global market size will reach US$ 3910 million by 2024, from US$ 3230 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in PEGylated Proteins business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of PEGylated Proteins market by product type, application, key manufacturers and key regions and countries.
This study considers the PEGylated Proteins value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor Viii
Monoclonal Antibodies
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global PEGylated Proteins consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of PEGylated Proteins market by identifying its various subsegments.
Focuses on the key global PEGylated Proteins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the PEGylated Proteins with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of PEGylated Proteins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global PEGylated Proteins Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global PEGylated Proteins Consumption 2014-2024
- 2.1.2 PEGylated Proteins Consumption CAGR by Region
- 2.2 PEGylated Proteins Segment by Type
- 2.2.1 Colony Stimulating Factors
- 2.2.2 Interferons
- 2.2.3 Erythropoietin (EPO)
- 2.2.4 Recombinant Factor Viii
- 2.2.5 Monoclonal Antibodies
- 2.2.6 Others
- 2.3 PEGylated Proteins Consumption by Type
- 2.3.1 Global PEGylated Proteins Consumption Market Share by Type (2014-2019)
- 2.3.2 Global PEGylated Proteins Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global PEGylated Proteins Sale Price by Type (2014-2019)
- 2.4 PEGylated Proteins Segment by Application
- 2.4.1 Cancer Treatment
- 2.4.2 Hepatitis
- 2.4.3 Chronic Kidney Disease
- 2.4.4 Leukemia
- 2.4.5 SCID
- 2.4.6 Rheumatoid Arthritis & Crohn's Disease
- 2.4.7 Others
- 2.5 PEGylated Proteins Consumption by Application
- 2.5.1 Global PEGylated Proteins Consumption Market Share by Application (2014-2019)
- 2.5.2 Global PEGylated Proteins Value and Market Share by Application (2014-2019)
- 2.5.3 Global PEGylated Proteins Sale Price by Application (2014-2019)
3 Global PEGylated Proteins by Players
- 3.1 Global PEGylated Proteins Sales Market Share by Players
- 3.1.1 Global PEGylated Proteins Sales by Players (2017-2019)
- 3.1.2 Global PEGylated Proteins Sales Market Share by Players (2017-2019)
- 3.2 Global PEGylated Proteins Revenue Market Share by Players
- 3.2.1 Global PEGylated Proteins Revenue by Players (2017-2019)
- 3.2.2 Global PEGylated Proteins Revenue Market Share by Players (2017-2019)
- 3.3 Global PEGylated Proteins Sale Price by Players
- 3.4 Global PEGylated Proteins Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global PEGylated Proteins Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players PEGylated Proteins Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 PEGylated Proteins by Regions
- 4.1 PEGylated Proteins by Regions
- 4.1.1 Global PEGylated Proteins Consumption by Regions
- 4.1.2 Global PEGylated Proteins Value by Regions
- 4.2 Americas PEGylated Proteins Consumption Growth
- 4.3 APAC PEGylated Proteins Consumption Growth
- 4.4 Europe PEGylated Proteins Consumption Growth
- 4.5 Middle East & Africa PEGylated Proteins Consumption Growth
5 Americas
- 5.1 Americas PEGylated Proteins Consumption by Countries
- 5.1.1 Americas PEGylated Proteins Consumption by Countries (2014-2019)
- 5.1.2 Americas PEGylated Proteins Value by Countries (2014-2019)
- 5.2 Americas PEGylated Proteins Consumption by Type
- 5.3 Americas PEGylated Proteins Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC PEGylated Proteins Consumption by Countries
- 6.1.1 APAC PEGylated Proteins Consumption by Countries (2014-2019)
- 6.1.2 APAC PEGylated Proteins Value by Countries (2014-2019)
- 6.2 APAC PEGylated Proteins Consumption by Type
- 6.3 APAC PEGylated Proteins Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe PEGylated Proteins by Countries
- 7.1.1 Europe PEGylated Proteins Consumption by Countries (2014-2019)
- 7.1.2 Europe PEGylated Proteins Value by Countries (2014-2019)
- 7.2 Europe PEGylated Proteins Consumption by Type
- 7.3 Europe PEGylated Proteins Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa PEGylated Proteins by Countries
- 8.1.1 Middle East & Africa PEGylated Proteins Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa PEGylated Proteins Value by Countries (2014-2019)
- 8.2 Middle East & Africa PEGylated Proteins Consumption by Type
- 8.3 Middle East & Africa PEGylated Proteins Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 PEGylated Proteins Distributors
- 10.3 PEGylated Proteins Customer
11 Global PEGylated Proteins Market Forecast
- 11.1 Global PEGylated Proteins Consumption Forecast (2019-2024)
- 11.2 Global PEGylated Proteins Forecast by Regions
- 11.2.1 Global PEGylated Proteins Forecast by Regions (2019-2024)
- 11.2.2 Global PEGylated Proteins Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global PEGylated Proteins Forecast by Type
- 11.8 Global PEGylated Proteins Forecast by Application
12 Key Players Analysis
- 12.1 ENZON Pharmaceuticals
- 12.1.1 Company Details
- 12.1.2 PEGylated Proteins Product Offered
- 12.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 ENZON Pharmaceuticals News
- 12.2 Merck Sharp & Dohme
- 12.2.1 Company Details
- 12.2.2 PEGylated Proteins Product Offered
- 12.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Merck Sharp & Dohme News
- 12.3 Roche
- 12.3.1 Company Details
- 12.3.2 PEGylated Proteins Product Offered
- 12.3.3 Roche PEGylated Proteins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Roche News
- 12.4 Pfizer
- 12.4.1 Company Details
- 12.4.2 PEGylated Proteins Product Offered
- 12.4.3 Pfizer PEGylated Proteins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Pfizer News
- 12.5 Amgen
- 12.5.1 Company Details
- 12.5.2 PEGylated Proteins Product Offered
- 12.5.3 Amgen PEGylated Proteins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Amgen News
- 12.6 UCB
- 12.6.1 Company Details
- 12.6.2 PEGylated Proteins Product Offered
- 12.6.3 UCB PEGylated Proteins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 UCB News
- 12.7 Crealta (Savient)
- 12.7.1 Company Details
- 12.7.2 PEGylated Proteins Product Offered
- 12.7.3 Crealta (Savient) PEGylated Proteins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Crealta (Savient) News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on PEGylated Proteins . Industry analysis & Market Report on PEGylated Proteins is a syndicated market report, published as Global PEGylated Proteins Market Growth 2019-2024. It is complete Research Study and Industry Analysis of PEGylated Proteins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
